Thus, CYLD is upregulated in MDMs of AD patients and impairs the control of S. aureus in M1-polarized MDMs, demonstrating that CYLD is a macrophage intrinsic inhibitor of the control of S. aureus. Here, CYLD is linked to Alzheimer disease.